In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

This has spurred interest in identifying supplementary methods for BC surveillance, with plasma-derived cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA) emerging as promising biomarkers.

The need for non-invasive biomarkers to monitor transplant health is growing. Donor-derived cell-free DNA (dd-cfDNA) is a fragment of DNA released from the donor’s organ into the recipient's ...

Study: Evaluation of cell-free DNA approaches for multi-cancer early ... in the blood and other bodily fluids outside of cells (cfDNA) has led to several blood-based cfDNA tests.

Cell-free DNA (cfDNA) is a noninvasive and informative disease biomarker, providing relevant information regarding disease characteristics and origins. Its use in clinical diagnostics was previously ...

Ever since its first discovery in 1948, circulating cell-free DNA (cfDNA) has captured the attention and imagination of researchers. Its use as a minimally invasive, informative, and dynamic biomarker ...

These small fragments of nucleic acids are widely known as cell-free DNA (cfDNA). Scientists have been aware of such degraded fragments of nucleic acids in body fluids since 1948. But only in the ...

So, in an effort to design more widely available approaches to study SCLC, the MacPherson and Ha labs collaborated to characterize cell free DNA (cfDNA) in their recent publication in Science Advances ...